Asthma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with asthma and are receiving a medicine called tezepelumab, or who are receiving high-intensity standard treatment for severe asthma, at some point during the study period.
Who may not be able to join:
- People who do not have at least 12 months of medical records available before the study start date.
- People who were under 12 years of age at the study start date.
- People with a history of a heart condition present from birth (congenital heart disease) or who have had a heart transplant.
- People who have had a non-fatal heart attack or stroke in the 180 days before the study start date (confirm with trial site).
- People who have experienced the specific health outcome being studied in the 180 days before the study start date (confirm with trial site for details).
- For one part of the study, people who were taking a different biologic medicine (not tezepelumab) at or around the study start date, within a specific washout window based on how long that medicine stays in the body.
- People whose health profile cannot be closely matched to another participant for comparison purposes, based on factors such as the type and length of standard treatment received in the 12 months before the study start date (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Peter Egger, IQVIA Pty Ltd
Phone: 1-877-240-9479
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
composite outcome MACE
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.